-
IntroducedJan 14, 2020
-
Passed Assembly
-
Passed Senate
-
Signed into Law
Provides that purchase of insulin is not subject to deductible; requires health insurers to limit copayments and coinsurance for insulin; requires insulin manufacturers to submit report to Commissioner of Banking and Insurance.***
Last Action See all actions
Assembly • Jun 16, 2021: Reported out of Assembly Comm. with Amendments, 2nd Reading
Latest Bill Text See all bill texts
Official Summary/Bill Text
Comments on A 954
Tweets
Whip Lists
Sponsors
Votes
Actions
- Jun 16, 2021 | Assembly
- Reported out of Assembly Comm. with Amendments, 2nd Reading
- Mar 17, 2021 | Assembly
- Recommitted to Assembly Appropriations Committee
- Feb 24, 2021 | Assembly
- Reported out of Assembly Comm. with Amendments, 2nd Reading
- Feb 13, 2020 | Assembly
- Reported as an Assembly Committee Substitute and Referred to Assembly Appropriations Committee
- Jan 14, 2020 | Assembly
- Introduced, Referred to Assembly Financial Institutions and Insurance Committee
Documents
- Assembly Committee Substitute A653 A1669HTML
- Assembly Committee Substitute A653 A1669PDF
- Statement AFI 2/13/2020 ACS A653 A1669HTML
- Statement AFI 2/13/2020 ACS A653 A1669PDF
- Fiscal Estimate 2/11/21; ACS A653 A1669HTML
- Fiscal Estimate 2/11/21; ACS A653 A1669PDF
- Statement AAP 2/24/21 ACS A653 A1669HTML
- Statement AAP 2/24/21 ACS A653 A1669PDF
- Fiscal Estimate 3/3/21; 1R ACS A653 A1669HTML
- Fiscal Estimate 3/3/21; 1R ACS A653 A1669PDF
- Reprint Of Substitute A653 A1669HTML
- Reprint Of Substitute A653 A1669PDF
- Statement 6/16/21 1R ACSHTML
- Statement 6/16/21 1R ACSPDF
- Fiscal Estimate 6/24/21; 2R ACSHTML
- Fiscal Estimate 6/24/21; 2R ACSPDF